On the basis of region, theglobal meningitis diagnostics testing market is segmented into North America,Latin America, Europe, Asia Pacific, Middle East, and Africa.
Geographically, North America isexpected to hold dominant position in the global MeningitisDiagnostic Testing Market over the forecast period, owing to early adoptionof diagnostic technologies by the major players. Moreover, major players in theNorth America meningitis diagnostic testing market are focused on adoptingacquisition and collaboration strategies to enhance their market share. This inturn is expected to boost the market growth. For instance, in September 2018,Quest Diagnostics acquired the U.S. laboratory services business of Oxford Immunotec.This acquisition is expected to expand capabilities of Quest Diagnostics ininfectious disease diagnostics to accelerate growth of the company byincreasing access to diagnostic innovation.
Meningitis is an infectioncharacterized by the inflammation of meninges. The meninges are the three layerof protective tissue consisting of dura mater, arachnoid mater, and pia materthat surround the neuraxis. Neuraxis represents the direction in which thecentral nervous system lies. The most common causes of meningitis are bacteriaand viruses and less common causes include parasites and fungi. The symptoms ofmeningitis include, severe headache, vomiting, fever, stiff neck, sensitivityto light, and distinctive skin rash. Meningitis caused by bacteria is moresevere than that by virus. It is challenging to diagnose meningitis as it showsmost common symptoms. Meningitis can be diagnosed by performing blood test tocheck for the presence of bacteria or viruses that can cause the disease.Lumbar puncture can also be performed in which cerebrospinal fluid (CSF) istaken from the base of the spine and checked for the presence of bacteria orviruses. Bacterial meningitis can be treated with a combination of severalantibiotics.
Meningitis Diagnostic TestingMarket Drivers
Development of novel technologiesthat require less time in diagnosis of meningitis is a major factor formeningitis diagnostic testing market growth. For instance, in April 2018,Ireland-based firm — HiberGene Diagnostics— introduced ‘HG Meningococcus test’—a combination test for meningococcal and pneumococcal meningitis that offersaccurate results in as little as 40 minutes. The new test is expected to cover90% cases of bacterial meningitis and help to speed up treatment of theillness.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2418
Furthermore, increasing researchand development activities to diagnose various type of meningitis is expectedto boost growth of the meningitis diagnostic testing market during the forecastperiod. For instance, in July 2018, Antrum Biotech and the University of CapeTown developed a new rapid test that can diagnose tuberculosis (TB) meningitiswithin two hours. The test is currently undergoing validation to enter themarket.
Meningitis Diagnostic TestingMarket- Regional Analysis
However, lack of access to newerdiagnostics technology by people in low income countries may restrain growth ofthe market. Moreover, lack of diagnostic laboratory infrastructure indeveloping countries is one of the major restraint for the MeningitisDiagnostic Testing Market. Nevertheless, this can be improved by using testthat do not require laboratory support including rapid tests for use at thepoint-of-care.
Furthermore, presence of keyplayers in Asia Pacific is expected to increase growth of the meningitisdiagnostics testing market in the region. For instance, in May 2017 SeegeneInc., announced that it has entered into a new strategic collaborationagreement with India-based Thermo Fisher Scientific. The collaboration wasfiled to the U.S Food and Drug Administration (FDA) for clearance of AllplexTMdiagnostic assay by Seegene Inc. Thermo Fisher filed for U.S.FDA clearance torun Seegene’s assays on Thermo Fisher’s QuantStudio 5 Real-Time PCR System.
Increasing prevalence ofmeningitis in Africa is expected to contribute to significant growth of themeningitis diagnostics market in the region. For instance, according to areport by World Health Organization (WHO), February 2018, major epidemics ofmeningococcal disease have occurred within the African meningitis belt(Lapeysonnie). These epidemics are very disruptive, requiring the establishmentof emergency treatment centers to offer proper treatment to the patients in theregion.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/meningitis-diagnostic-testing-market-2418
Meningitis Diagnostic TestingMarket - Competitive Landscape
Some of the key players operatingin the market include, Thermo Fisher Scientific, Inc., BioFire Diagnostics,Siemens, Quest Diagnostics, Bio-Rad Laboratories, Inc., Luminex Corporation,Seegene Inc., IMMY, ELITechGroup, Abbott, Pfizer, Nuron Biotech, GSK,MedImmune, Sanofi, Novartis, Baxter, Merck & Co., Biomed Pvt. Ltd, andothers.
Key Development
In 2018, Eurofins Viracor, Inc.,has launched 16S Next Generation Sequencing (NGS) bacterial meningitis test forthe diagnosis of meningitis.
In 2018, Fast Track Diagnosticsentered into partnership with University of Liverpool to create a commercialblood test to enhance the management and diagnosis of meningitis in patients.
In 2015, HiberGene Diagnostics,has received CE mark approval for its HG Meningococcus, a rapid test for thediagnosis of bacterial meningitis.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2418
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
